An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research.

[1]  T. Iwasaka,et al.  A lower serum level of middle-molecular-weight adiponectin is a risk factor for endometrial cancer , 2014, International Journal of Clinical Oncology.

[2]  Jing Wang,et al.  Health-related quality of life among participants in the SMART weight loss trial. , 2012, Applied nursing research : ANR.

[3]  M. Blüher.  Clinical Relevance of Adipokines , 2012, Diabetes & metabolism journal.

[4]  L. Niskanen,et al.  Serum adipokine levels in adults with a history of childhood maltreatment , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  B. Spiegelman,et al.  Molecular mechanisms of cancer development in obesity , 2011, Nature Reviews Cancer.

[6]  S. Tonstad,et al.  Validity of the SF-36 in Patients with Morbid Obesity , 2011, Obesity Facts.

[7]  K. Nadeau,et al.  Health-related quality of life in adolescents with comorbidities related to obesity. , 2011, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[8]  Yi Liu,et al.  Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation , 2011, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[9]  J. DeLany,et al.  Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: implications for cancer risk reduction. , 2011, Gynecologic oncology.

[10]  L. Lerescu,et al.  Serum levels of adipokines resistin and leptin in patients with colon cancer , 2010, Journal of medicine and life.

[11]  D. Geschwind,et al.  Prospective Identification, Isolation, and Profiling of a Telomerase-Expressing Subpopulation of Human Neural Stem Cells, using sox2 Enhancer-Directed Fluorescence-Activated Cell Sorting , 2010, The Journal of Neuroscience.

[12]  Imke Schamarek,et al.  Adiponectin and negative mood in healthy premenopausal and postmenopausal women , 2010, Hormones and Behavior.

[13]  S. Morris,et al.  Socioeconomic variation in the impact of obesity on health-related quality of life. , 2010, Social science & medicine.

[14]  M. Zwahlen,et al.  Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[15]  C. Tai,et al.  Prospective study of health‐related quality of life after Roux‐en‐Y bypass surgery for morbid obesity , 2010, The British journal of surgery.

[16]  K. Yoshihara,et al.  Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects. , 2010, Gynecologic oncology.

[17]  G. MacQueen,et al.  The Role of Adipokines in Understanding the Associations between Obesity and Depression , 2010, Journal of obesity.

[18]  C. Caruso,et al.  The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases , 2010, Mediators of inflammation.

[19]  G. Mantovani,et al.  Correlation of body mass index and leptin with tumor size and stage of disease in hormone-dependent postmenopausal breast cancer: preliminary results and therapeutic implications , 2010, Journal of Molecular Medicine.

[20]  Lora E Burke,et al.  SMART trial: A randomized clinical trial of self-monitoring in behavioral weight management-design and baseline findings. , 2009, Contemporary clinical trials.

[21]  Mengling Liu,et al.  Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. , 2009, European cytokine network.

[22]  Mengling Liu,et al.  Reproducibility of Serum Pituitary Hormones in Women , 2008, Cancer Epidemiology Biomarkers & Prevention.

[23]  Jaw-Town Lin,et al.  Health-related Quality of Life in Adult Patients with Morbid Obesity Coming for Bariatric Surgery , 2008, Obesity surgery.

[24]  Roger B. Davis,et al.  Comparing the SF-12 and SF-36 health status questionnaires in patients with and without obesity , 2008, Health and quality of life outcomes.

[25]  Xin-Yun Lu.  The leptin hypothesis of depression: a potential link between mood disorders and obesity? , 2007, Current opinion in pharmacology.

[26]  M Sullivan,et al.  Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study , 2007, International Journal of Obesity.

[27]  E. Surmacz.  Obesity hormone leptin: a new target in breast cancer? , 2007, Breast Cancer Research.

[28]  M. Szymańska,et al.  Expression of Leptin, Leptin Receptor, and Hypoxia‐Inducible Factor 1α in Human Endometrial Cancer , 2007, Annals of the New York Academy of Sciences.

[29]  L. Burke,et al.  A Randomized Clinical Trial Testing Treatment Preference and Two Dietary Options in Behavioral Weight Management: Preliminary Results of the Impact of Diet at 6 Months—PREFER Study , 2006, Obesity.

[30]  F. Anania,et al.  Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. , 2006, Endocrine-related cancer.

[31]  Lora E Burke,et al.  PREFER study: a randomized clinical trial testing treatment preference and two dietary options in behavioral weight management--rationale, design and baseline characteristics. , 2006, Contemporary clinical trials.

[32]  P. Stattin,et al.  Obesity and colon cancer: Does leptin provide a link? , 2004, International journal of cancer.

[33]  D. Trichopoulos,et al.  Leptin and Body Mass Index in Relation to Endometrial Cancer Risk , 2002, Annals of Nutrition and Metabolism.

[34]  G. Marchesini,et al.  Health-related quality of life in obesity: the role of eating behaviour. , 2000, Diabetes, nutrition & metabolism.

[35]  K. Fontaine,et al.  Impact of weight loss on Health-Related Quality of Life , 1999, Quality of Life Research.

[36]  P. Freedson,et al.  Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program. , 1998, Obesity research.

[37]  I. Ulman-Włodarz,et al.  Adiponectin to leptin index as a marker of endometrial cancer in postmenopausal women with abnormal vaginal bleeding: an observational study. , 2012, Neuro endocrinology letters.

[38]  A. Vasku,et al.  Relationship of resistin levels with endometrial cancer risk. , 2011, Neoplasma.

[39]  Paolo Toniolo,et al.  Reproducibility of serum cytokines and growth factors. , 2009, Cytokine.

[40]  M. Gangemi,et al.  Obesity as a risk factor for endometrial cancer. , 1987, Clinical and experimental obstetrics & gynecology.